Merck appoints Marcus Kuhnert as Group CFO

9 May 2014
merck-serono-big

Germany’s Merck (MRK: DE) has appointed Marcus Kuhnert as Group Chief Financial Officer. Mr Kuhnert will become a member of Merck’s Executive Board with unlimited personal liability as of August 1, 2014.

Mr Kuhnert has been CFO of Henkel’s Laundry & Home Care business unit since 2010. He started his career as Corporate Controller at Henkel in 1999 and as of 2003 headed Group Financial Statements & Subsidiary Controlling. As of 2007, he worked in Singapore as Regional General Manager for Henkel-Adhesive in South East Asia and played a key role in integrating the largest acquisition in Henkel’s history. In 2008 he took charge of the CEO Office and Strategy Development as well as Corporate Communications ad interim as of 2009.

Mr Kuhnert studied at the Technical University of Darmstadt, Germany, where he earned a combined master’s degree in business administration and mechanical engineering and a PhD at the Institute for Finance and Controlling.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical